Sign In
Buy AMGN
$345.60
+7.38 (+2.18%)
At Close: Jun 04, 2026
Why Amgen (AMGN) is a Top Value Stock for the Long-Term
10:46am, Monday, 13'th Jan 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
3 High-Yield Dividend Stocks to Buy in 2025
09:00am, Monday, 13'th Jan 2025
High-yield dividend stocks may not appeal to some investors. However, if you're among those investors looking for income, stocks that pay dividends regularly can be great additions to your portfolio.
AMGEN TO PRESENT AT 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE
04:01pm, Wednesday, 08'th Jan 2025
THOUSAND OAKS, Calif. , Jan. 8, 2025 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2025 J.P.
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Asher Biotherapeutics, a biotechnology company developing precisely-targeted immunotherapies for cancer and infectious diseases, today announced a clinica
Amgen (AMGN) Advances While Market Declines: Some Information for Investors
07:17pm, Tuesday, 07'th Jan 2025
Amgen (AMGN) closed at $262.05 in the latest trading session, marking a +1.34% move from the prior day.
Amgen (AMGN) Stock Sinks As Market Gains: Here's Why
07:11pm, Monday, 06'th Jan 2025
Amgen (AMGN) concluded the recent trading session at $258.59, signifying a -1.01% move from its prior day's close.
Will Amgen (AMGN) Beat Estimates Again in Its Next Earnings Report?
01:11pm, Monday, 06'th Jan 2025
Amgen (AMGN) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Amgen: The Buying Opportunity Has Now Arrived (Rating Upgrade)
07:30am, Monday, 06'th Jan 2025
Since my previous article, shares of Amgen meaningfully lagged the S&P 500 index. The company's revenue and non-GAAP EPS climbed higher in the third quarter. Amgen's deleveraging efforts are progressi
CAMBRIDGE, England--(BUSINESS WIRE)--Today, Amgen announced that the UK's Medicines and Healthcare products Regulatory Agency (MHRA) has granted a conditional marketing authorisation to IMDYLLTRA® fo
Amgen: Blockbusters, Emerging Therapies, And Investment Potential
07:18pm, Sunday, 05'th Jan 2025
Amgen's strong product portfolio and pipeline developments, including, but not limited to, IMDELLTRA and MariTide, support a "Strong Buy" rating for long-term investors despite upcoming patent expirat
Big Blue Chip Dividends? Try These ‘Dogs' Up To 6.8%
11:49am, Saturday, 04'th Jan 2025
The Dogs of the Dow 2025 pay big dividends—up to 6.8%! Collectively they yield three-times what the broader market pays.
Prediction: These 3 Healthcare Stocks Will Soar in 2025
06:48am, Saturday, 04'th Jan 2025
No one knows for sure what the new year will hold for the market. However, some stocks' chances for success look particularly good.
Amgen Inc. (AMGN) Is a Trending Stock: Facts to Know Before Betting on It
10:01am, Friday, 03'rd Jan 2025
Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Should You Buy the 3 Highest-Paying Dividend Stocks in the Dow Jones?
08:30am, Friday, 03'rd Jan 2025
The Dow Jones Industrial Average contains 30 handpicked companies that are, or at least once were, leaders in their respective industries. This makes the index an interesting hunting ground for high-
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks Delivering High-Dividend Yields
07:39am, Friday, 03'rd Jan 2025
During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high
